| __timestamp | Biogen Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 19586000 |
| Thursday, January 1, 2015 | 2012800000 | 29135000 |
| Friday, January 1, 2016 | 1973300000 | 42791000 |
| Sunday, January 1, 2017 | 2253600000 | 49577000 |
| Monday, January 1, 2018 | 2597200000 | 89209000 |
| Tuesday, January 1, 2019 | 2280600000 | 69099000 |
| Wednesday, January 1, 2020 | 3990900000 | 75961000 |
| Friday, January 1, 2021 | 2501200000 | 90467000 |
| Saturday, January 1, 2022 | 2231100000 | 74552000 |
| Sunday, January 1, 2023 | 2702600000 | 91593000 |
| Monday, January 1, 2024 | 2041800000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Biogen Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Biogen consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2020 at nearly double its 2014 levels. This reflects Biogen's strategic focus on pioneering treatments and maintaining its competitive edge.
Conversely, Supernus Pharmaceuticals, while showing a steady increase in R&D spending, operates on a smaller scale. By 2023, Supernus's R&D expenses had grown by approximately 368% from 2014, highlighting its commitment to expanding its research capabilities. This comparison underscores the diverse strategies within the pharmaceutical sector, where both large-scale and niche players strive for innovation, albeit with different scales and scopes.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.